Skip to main content
. 2015 May 4;13(1):dose-response.14-023.Alleman. doi: 10.2203/dose-response.14-023.Alleman

FIGURE 1.

FIGURE 1.

Reductions in infarct size are abolished by inhibiting NADPH Oxidase (with pre-exercise treatment of apocynin or Vas2870) during exercise. Inhibition of mitochondrial ROS during exercise (with pre-exercise administration of TEMPO or the mitochondria-targeting peptide Bendavia) had no effect on exercise cardioprotection. Figure reproduced from Frasier et al., Cardiovascular Research 2013, with permission (pending).